Faculty

Institution

Unit

Venue

Jong-In Park

Professor; Eminent Scholar

Medical College of Wisconsin

Affiliations

Biochemistry

Enzymology and Metabolism

Graduate School

Pancreatic Cancer Program

Jong-in Park is currently serving as a Biochemistry Professor; Eminent Scholar at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jong-In Park

Medical College of Wisconsin

Professor; Eminent Scholar

You can click a keyword to filter the displayed items

molecular biology cell biology tumor biology cancer research oncogenes cancer cells cell signaling oncology cancer biology pharmacology systems biology signal transduction signaling pathways thyroid molecular cancer gene expression medicinal research molecular and cellular biology cell regulation cancer treatment cancer genetics molecular cell biology cell death tumor microenvironment leukemia cancer discovery cancer growth tumor suppressors tumor targeting cancer genomics endocrine-related cancers cellular physiology molecular science mitochondrial function enzyme inhibition structural molecular biology inhibitory activity molecular regulation receptor tyrosine kinases thyroid disease biological chemistry redox biology anti-cancer agents endocrine oncology thyroid hormone cytokines mitophagy melanoma growth arrest cell research yeast cellular biology mitochondrial dynamics cell growth protein phosphorylation prostate cancer cells key site tumoral pathology mitochondrial biogenesis cellular immune responses cellular regulatory mechanism transplantation medicine stress responses saccharomyces cerevisiae cytokine system freeze-thaw stress differential regulation chondrocyte proteoglycan synthesis metastatic potential freeze-thaw stress response growth phase nutritional state yeast saccharomyces cerevisiae molecular activity resistance mechanisms autocrine-paracrine growth inhibition cell cycle pathology cell metabolism drug resistance oncogenic agent

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract Ct227: Quantum Mechanics-Based Multi-Tensor AI/ML Discovery of a Whole-Transcriptome Predictor of Response and Survival in Patients Treated With Dabrafenib and Trametinib in the Tumor-Agnostic Small-Cohort Nci-Match Subprotocol H With Validation in Three Tumor Types in Tcga. Cancer Research (2025)

Orly AlterJong-In ParkPing GuanAsaf ZviranLyndsay N. Harris

cancer imagingcancer researchcancer biologybiostatisticstranscriptomewhole-transcriptome predictorcancer discoverysurvival analysisclinical researchdisease progression

Activity-Dependent Effects of Erk1/2 on Hepatic Ischemia-Reperfusion Injury. Transplantation Proceedings (2025)

hepatologytranslational medicineliver physiologyinflammationoxidative stressdrug-induced liver injuryhepatic ischemia-reperfusion injurypharmacologyvascular biologyphysiologyfree radical biologyhepatotoxicityreperfusion injurycell death

Abstract 1099: Combined Mek and Ret Inhibition Overcomes Resistance to Single Agent Ret Inhibition in Medullary Thyroid Cancer. Cancer Research (2024)

Arwa FallatahAbdelrahman RahmySophia KhanHsien-chao ChouKerstin Heselmeyer-HaddadDarawalee WangsaDavid MilewskiYong KimRobert HawleyYoung SongXiaohu ZhangCraig ThomasJun S. WeiJong-In ParkJohn GlodJaved Khan

cancer immunotherapycancer biologypharmacologyendocrine oncologytumor biologycellular therapycancer researchoncologycancer carecancer treatmentcancer genomicsgeneticsmedicinal researchsurgical oncologycancer imagingmedullary thyroid cancercancer managementclinical researchhealth sciences

Dabrafenib and Trametinib in Patients With Tumors With Braf V600E/K Mutations: Updated Results From Nci-Match Arm H.. Journal of Clinical Oncology (2024)

April K.S. SalamaVictoria WangErin Renee MacraeJong-In ParkHelen X. ChenRobert James GrayLisa McShaneLawrence RubinsteinP. Mickey WilliamsStanley R. HamiltonDeborah Kay ArmstrongJames V. TricoliBarbara A. ConleyCarlos L. ArteagaLyndsay HarrisPeter J. O'DwyerAlice P. ChenKeith Flaherty

tumor biologyoncologyradiation oncologycancer researchmolecular cancerpharmacologytumor targetinggene therapyclinical researchcancer geneticsmedicinal research

Erk1/2 Interaction With Dhps Regulates Eif5A Deoxyhypusination Independently of Erk Kinase Activity. Cell Reports (2024)

Andrew E. BeckerPaweł KochanowskiPui-Kei WuElżbieta WątorWenjing ChenKoushik GuchhaitArtur P. BielaPrzemysław GrudnikJong-In Park

cell biologycell signalingcell interactionserk kinase activitymolecular biologydhps regulates

Erlotinib Combination With a Mitochondria-Targeted Ubiquinone Effectively Suppresses Pancreatic Cancer Cell Survival. World Journal of Gastroenterology (2024)

Pui-Yin LeungWenjing ChenAnissa N SariPoojitha SitaramPui-Kei WuSusan TsaiJong-In Park

mitochondria-targeted ubiquinonegastroenterologyoncologycancer researchcancer cellspancreatic cancerpharmacologyerlotinib combination

Wenjing ChenYoung Shin SongHan Sai LeeChien-Wei LinJunguee LeeYea Eun KangSeon-Kyu KimSeon-Young KimYoung Joo ParkJong-In Park

endocrinologythyroidcell biologythyroid diseaseoncogenesendocrine-related cancersthyroid hormoneestrogen-related receptor alphatumor subtype-specific regulationpsychoneuroendocrinologyendocrine oncologyhormonal receptortarget gene networks

Selpercatinib Combination With the Mitochondria-Targeted Antioxidant Mitoq Effectively Suppresses Ret–Mutant Thyroid Cancer. npj Precision Oncology (2024)

Wenjing ChenSophie DreamPui-Yin LeungPui-Kei WuStuart WongJong-In Park

selpercatinib combinationcancer researchoxidative stressoncologythyroidtumor suppressorsmitochondria-targeted antioxidant mitoqoncogenesret-mutant thyroid cancerpharmacologyantioxidants

EDITORIAL: The Role of Mortalin in Biology and Disease. Frontiers in Cell and Developmental Biology (2023)

Jong-In Park

developmental biologymolecular and cellular biologycellular biologycell biologycell and molecular biologymolecular biology

Mapk-Erk Pathway. International Journal of Molecular Sciences (2023)

Jong-In Park

pathway analysissignaling pathwaysmolecular and cellular biologybiomolecular engineeringmolecular sciencecell signalingmolecular biophysicsstructural molecular biologysystems biologymapk-erk pathwaysignal transductionmolecular biologymolecular modellingmedicinal research

1
2
3
4
5
9
10 / page

Jong-In Park

Professor; Eminent Scholar

Medical College of Wisconsin

Affiliations

Biochemistry

Enzymology and Metabolism

Graduate School

Pancreatic Cancer Program

Jong-in Park is currently serving as a Biochemistry Professor; Eminent Scholar at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jong-In Park

Medical College of Wisconsin

Professor; Eminent Scholar

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Orly AlterJong-In ParkPing GuanAsaf ZviranLyndsay N. Harris

cancer imagingcancer researchcancer biologybiostatisticstranscriptomewhole-transcriptome predictorcancer discoverysurvival analysisclinical researchdisease progression

Activity-Dependent Effects of Erk1/2 on Hepatic Ischemia-Reperfusion Injury. Transplantation Proceedings (2025)

Abstract 1099: Combined Mek and Ret Inhibition Overcomes Resistance to Single Agent Ret Inhibition in Medullary Thyroid Cancer. Cancer Research (2024)

Dabrafenib and Trametinib in Patients With Tumors With Braf V600E/K Mutations: Updated Results From Nci-Match Arm H.. Journal of Clinical Oncology (2024)

tumor biologyoncologyradiation oncologycancer researchmolecular cancerpharmacologytumor targetinggene therapyclinical researchcancer geneticsmedicinal research

Erk1/2 Interaction With Dhps Regulates Eif5A Deoxyhypusination Independently of Erk Kinase Activity. Cell Reports (2024)

Andrew E. BeckerPaweł KochanowskiPui-Kei WuElżbieta WątorWenjing ChenKoushik GuchhaitArtur P. BielaPrzemysław GrudnikJong-In Park

cell biologycell signalingcell interactionserk kinase activitymolecular biologydhps regulates

Erlotinib Combination With a Mitochondria-Targeted Ubiquinone Effectively Suppresses Pancreatic Cancer Cell Survival. World Journal of Gastroenterology (2024)

Pui-Yin LeungWenjing ChenAnissa N SariPoojitha SitaramPui-Kei WuSusan TsaiJong-In Park

mitochondria-targeted ubiquinonegastroenterologyoncologycancer researchcancer cellspancreatic cancerpharmacologyerlotinib combination

Wenjing ChenYoung Shin SongHan Sai LeeChien-Wei LinJunguee LeeYea Eun KangSeon-Kyu KimSeon-Young KimYoung Joo ParkJong-In Park

Selpercatinib Combination With the Mitochondria-Targeted Antioxidant Mitoq Effectively Suppresses Ret–Mutant Thyroid Cancer. npj Precision Oncology (2024)

Wenjing ChenSophie DreamPui-Yin LeungPui-Kei WuStuart WongJong-In Park

selpercatinib combinationcancer researchoxidative stressoncologythyroidtumor suppressorsmitochondria-targeted antioxidant mitoqoncogenesret-mutant thyroid cancerpharmacologyantioxidants

EDITORIAL: The Role of Mortalin in Biology and Disease. Frontiers in Cell and Developmental Biology (2023)

Jong-In Park

developmental biologymolecular and cellular biologycellular biologycell biologycell and molecular biologymolecular biology

Mapk-Erk Pathway. International Journal of Molecular Sciences (2023)

Jong-In Park

1
2
3
4
5
9
10 / page

Similar Faculty Members

Ratna K Vadlamudi

Institution

University of Texas Health Science Center at San Antonio

molecular cancer

estrogen signaling

Besim Ogretmen, Ph.D

Institution

Medical University of South Carolina

cancer pathogenesis

cancer biology

Danny Dhanasekaran

Institution

University of Oklahoma

metabolomic variations

transcriptome

Daniel Devor

Institution

University of Pittsburgh

cellular differentiation

molecular pathology

Xiao-Ming Yin

Institution

Tulane University

hepatotoxicity

hepatology

Satdarshan Monga

Institution

University of Pittsburgh

cellular basis

regeneration (biology)

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Cheryl Walker, Ph.D.

Institution

Baylor College of Medicine

molecular metabolism

epigenetics

Nagireddy Putluri, Ph.D

Institution

Baylor College of Medicine

molecular metabolism

cancer genetics

Yigang Wang

Institution

University of Cincinnati

stem cell research

medicine

Similar Faculty Members

Ratna K Vadlamudi

Institution

University of Texas Health Science Center at San Antonio

molecular cancer

estrogen signaling

Besim Ogretmen, Ph.D

Institution

Medical University of South Carolina

cancer pathogenesis

cancer biology

Danny Dhanasekaran

Institution

University of Oklahoma

metabolomic variations

transcriptome

Daniel Devor

Institution

University of Pittsburgh

cellular differentiation

molecular pathology

Xiao-Ming Yin

Institution

Tulane University

hepatotoxicity

hepatology

Satdarshan Monga

Institution

University of Pittsburgh

cellular basis

regeneration (biology)

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Cheryl Walker, Ph.D.

Institution

Baylor College of Medicine

molecular metabolism

epigenetics

Nagireddy Putluri, Ph.D

Institution

Baylor College of Medicine

molecular metabolism

cancer genetics

Yigang Wang

Institution

University of Cincinnati

stem cell research

medicine